Latest news
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC - Urology TimesUrology Times · Sat, 08 Aug 2026 17:49:18 GMTUSPCC 2026: Point-Counterpoint 3: Treatment of Metastatic APMN/S Prostate Cancer: Metastasis Directed Radiation - UroTodayUroToday · Fri, 07 Aug 2026 01:04:09 GMTCAPItello-281 and the PTEN-Deficient Subset of Metastatic Hormone-Sensitive Prostate Cancer - Alicia Morgans - UroTodayUroToday · Thu, 06 Aug 2026 17:23:13 GMT